logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Benjamin M. Ellingson

Center for Computer Vision and Imaging Biomarkers
H指数:65
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial

新辅助PD1联合CTLA-4免疫检查点阻断在可手术切除的复发性胶质母细胞瘤中的应用：一项随机手术窗口期试验

Nature Communications
IF15.7
2026-09-050
OA
Lu Sun; Lauren F. Markus; Julio C. Sanchez; Thomas J. Lai; Eudocia Quant Lee; Gang Li; Jiyoon Kim; Zian Zhuang; Brenda Acevedo; Richard G. Everson; Ingo K. Mellinghoff; Elisa Aquilanti; L. Nicolas Gonzalez Castro; J. Ricardo McFaline-Figueroa; Lakshmi Nayak; Rameen Beroukhim; Robert A. Chong; Jacqueline Stone; Thomas Kaley; Lauren Schaff; Jessica Wilcox; Catharina Westergaard; Alyssa Russ; Maria Lavallee; Ugonma Chukwueke; Annick D. Van den Abbeele; Michael Lim; Benjamin M. Ellingson; David A. Reardon; Timothy F. Cloughesy; Robert M. Prins; Patrick Y. Wen
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial

抗LAG-3抗体联合或不联合抗PD-1抗体治疗复发性胶质母细胞瘤：一项I期临床试验

Nature Medicine
IF50
2026-07-100
OAAI
Michael Lim; Xiaobu Ye; Anna F. Piotrowski; Arati Desai; Manmeet S. Ahluwalia; Tobias Walbert; Glenn Lesser; Benjamin M. Ellingson; David M. Peereboom; Joy D. Fisher; Serena Desideri; Christina Jackson; Ayush Pant; Aanchal Jain; Rohit Verma; Benjamin Oberlton; Hadeesha Piyadasa; Chetan Bettegowda; Logan Engle; Janis Taube; Sean C. Bendall; John Choi; Jan Drappatz; Frank S. Lieberman; Lawrence R. Kleinberg; Drew M. Pardoll; Louis B. Nabors; Patrick Y. Wen; Stuart A. Grossman
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-Mutant Gliomas treated with Bevacizumab

贝伐珠单抗治疗复发性对比增强型IDH突变型胶质瘤的临床和放射学预后因素

Neuro-Oncology Advances
IF4.1
2026-04-070
OA
Collin T Le; Francesco Sanvito; Chuyin Yang; Blaine S C Eldred; Catalina Raymond; Terry J Prins; Addison Fisher; Tie Li; Linda M Liau; Robert A Chong; Phioanh Leia Nghiemphu; Timothy F Cloughesy; Albert Lai; Benjamin M Ellingson; null
CTIM-12. DUAL IMMUNE CHECKPOINT BLOCKADE FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES

CTIM-12. 双免疫检查点阻断治疗可手术切除的复发性胶质母细胞瘤：临床与分子结局

Neuro-Oncology
IF13.4
2025-11-110
OA
Lu Sun; Eudocia Quant Lee; Gang Li; David A Reardon; Brenda Acevedo; Catharina Westergaard; Alyssa Russ; Richard G Everson; Benjamin M Ellingson; Ingo K Mellinghoff; Elisa Aquilanti; L Nicolas Gonzalez Castro; J Ricardo McFaline-Figueroa; Lakshmi Nayak; Rameen Beroukhim; Robert A Chong; Jacqueline Stone; Thomas Kaley; Lauren Schaff; Jessica wilcox; Maria Lavallee; Ugonma Chukwueke; Annick D Van den Abbeele; Michael Lim; Timothy F Cloughesy; Robert M Prins; Patrick Y Wen
IMG-64. Baseline imaging metrics stratifying progression-free survival and overall survival in primary central nervous system lymphoma treated with high-dose methotrexate

IMG-64. 基线影像学指标分层分析接受大剂量甲氨蝶呤治疗的原发性中枢神经系统淋巴瘤患者的无进展生存期和总生存期

Neuro-Oncology
IF13.4
2025-11-110
OA
Francesco Sanvito; Irina Kryukov; Giulio Cassanello; Patricia Young; Gianluca Nocera; Monica Mead; Herbet Eradat; Noriko Salamon; Benjamin Ellingson
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际，回顾科学增长与创新

Neuro-Oncology
IF13.4
2025-11-040
PRE
Macarena I de la Fuente; Priscilla K Brastianos; Bradley Gampel; Farshad Nassiri; David R Raleigh; Cristiane M Ida; Mohamed S Abdelbaki; Melike Pekmezci; Stephen Bagley; Jacob S Young; Rimas V Lukas; Angela C Hirbe; Benjamin M Ellingson; Javier Villanueva-Meyer; Anna Lasorella; Jann N Sarkaria; David H Gutmann; Daphne Haas-Kogan; Evanthia Galanis; Susan M Chang
Volumetric (3D) compared with traditional bidirectional (2D) assessment in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial

与接受vorasidenib或安慰剂治疗的Grade 2，异柠檬酸脱氢酶1/2突变（mIDH1/2）胶质瘤患者中，体素（3D）评估相较于传统双向（2D）评估在INDIGO III期试验中的比较

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Ellingson, Benjamin M.; Mellinghoff, Ingo; Van Den Bent, Martin J.; Blumenthal, Deborah T.; Touat, Mehdi; Peters, Katherine B.; Clarke, Jennifer L.; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P.; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F.; Arakawa, Yoshiki; Sepulveda, Juan M.; Wick, Wolfgang; Soffietti, Riccardo; Perry, James; Giglio, Pierre; De La Fuente, Macarena, I; Maher, Elizabeth; Zhao, Dan; Pandya, Shuchi S.; Steelman, Lori; Hassan, Islam; Wen, Patrick Y.; Cloughesy, Timothy F.
Contralateral neurofluid dynamics predict survival in IDH wild-type glioblastoma: A DTI-ALPS and free water imaging study

对侧神经流体动力学可预测IDH野生型胶质母细胞瘤的生存：一项DTI-ALPS和自由水成像研究

NEURO-ONCOLOGY
IF13.4
2025-11-010
PRE
Hagiwara, Akifumi; Uchida, Wataru; Ozawa, Takuya; Takabayashi, Kaito; Zou, Rui; Ellingson, Benjamin M.; Andica, Christina; Kikuta, Junko; Akashi, Toshiaki; Wada, Akihiko; Kumamaru, Kanako Kunishima; Kamagata, Koji; Akiyama, Osamu; Kondo, Akihide; Aoki, Shigeki
Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma

GBM AGILE更新：一项全球性、II/III期自适应平台试验，旨在评估新诊断和复发性胶质母细胞瘤中的多种治疗方案

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Lim, Michael; Berry, Donald; Berry, Nicholas; Colman, Howard; De Groot, John; Ellingson, Benjamin; Gan, Hui; Hyddmark, E. Viktoria; Johnson, Adam; Lassman, Andrew; Mellinghoff, Ingo; Perry, James; Sulman, Erik; Weller, Michael; Wen, Patrick; Cloughesy, Timothy; Network, Gbm Agile Trial
Volumetric tumor growth rate (TGR) modeling predicts clinical outcomes in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial

体积肿瘤生长率（TGR）建模预测了在INDIGO三期试验中，接受vorasidenib或安慰剂治疗的Grade 2、异柠檬酸脱氢酶1/2突变（mIDH1/2）胶质瘤患者的临床结局。

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Ellingson, Benjamin M.; Mellinghoff, Ingo; Van Den Bent, Martin J.; Blumenthal, Deborah T.; Touat, Mehdi; Peters, Katherine B.; Clarke, Jennifer L.; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P.; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F.; Arakawa, Yoshiki; Sepulveda, Juan M.; Wick, Wolfgang; Soffietti, Riccardo; Perry, James; Giglio, Pierre; De La Fuente, Macarena, I; Maher, Elizabeth; Zhao, Dan; Pandya, Shuchi S.; Steelman, Lori; Hassan, Islam; Wen, Patrick Y.; Cloughesy, Timothy F.
Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas

IDH突变型胶质瘤病理确诊恶性转化时的灌注、扩散及解剖MRI特征

NEURO-ONCOLOGY
IF13.4
2025-11-010
PRE
Cho, Nicholas S.; Le, Vien Lam; Teraishi, Ashley; Liu, Vicki; Sanvito, Francesco; Telesca, Donatello; Nakajo, Masanori; Wang, Chencai; Oshima, Sonoko; Eldred, Blaine S. C.; Yao, Jingwen; Nghiemphu, Phioanh L.; Salamon, Noriko; Cloughesy, Timothy F.; Lai, Albert; Ellingson, Benjamin M.
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial

Vorasidenib在IDH1突变或IDH2突变低级别胶质瘤（INDIGO）：一项随机、双盲、安慰剂对照、III期试验的次要和探索性终点

The Lancet Oncology
IF0
2025-10-290
PRE
Timothy F Cloughesy; Martin J van den Bent; Mehdi Touat; Deborah T Blumenthal; Katherine B Peters; Benjamin M Ellingson; Jennifer L Clarke; Joe Mendez; Shlomit Yust-Katz; Liam Welsh; Warren P Mason; Francois Ducray; Yoshie Umemura; Burt Nabors; Matthias Holdhoff; Andreas F Hottinger; Yoshiki Arakawa; Juan M Sepulveda; Wolfgang Wick; Riccardo Soffietti; James Perry; Pierre Giglio; Macarena de la Fuente; Elizabeth Maher; Andrew Bottomley; Adriana E Tron; Denise Yi; Dan Zhao; Shuchi S Pandya; Lori Steelman; Islam Hassan; Patrick Y Wen; Ingo K Mellinghoff
Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas

I期/II期和机会窗口研究：帕米帕利布与常规替莫唑胺联合治疗异柠檬酸脱氢酶突变型胶质瘤的复发病例

Neuro-Oncology
IF13.4
2025-10-160
PRE
David Schiff; Xiaobu Ye; Jing Li; Benjamin M Ellingson; Patrick Y Wen; Tobias Walbert; Jian Campian; Louis B Nabors; Byram H Ozer; Arati Desai; Antonio Omuro; Serena Desideri; Neeraja Danda; Stuart Grossman; Ranjit S Bindra

研究方向

暂未获取到该数据
T
Timothy F. Cloughesy
H 指数:128论文数:1,355被引数:6.3万
W
Whitney B. Pope
H 指数:69论文数:295被引数:1.5万
A
Albert Lai
H 指数:73论文数:511被引数:1.7万
P
Phioanh L. Nghiemphu
H 指数:56论文数:337被引数:1.1万
N
Noriko Salamon
H 指数:56论文数:503被引数:1.3万
L
Linda M. Liau
H 指数:83论文数:676被引数:3.4万
C
Catalina Raymond
H 指数:20论文数:146被引数:1,416
P
Patrick Y. Wen
H 指数:145论文数:1,930被引数:8.7万
J
Jingwen Yao
H 指数:18论文数:146被引数:1,025
C
Chencai Wang
H 指数:12论文数:87被引数:734